Our consultants have active academic, clinical and commercial research programs and are comprised of the current leaders in translating scientific discovery into clinical therapies. These Regenerative Medicine research programs aim to develop replacement tissues and organs while speeding up the availability of these treatments to patients. This expertise can be leveraged to assist you with the discovery and development of new products, pre-clinical evaluation, and collection of data for regulatory approval.
Examples of this expertise and active research programs include:
- Cell and Gene Therapy Research
- Biomaterial Development and Testing
- 3D Bioprinting and Tissue Engineering (30 organ portfolio)
- 3D Organoid and “Organ-on-a-chip” Technology
- Small Molecule and Drug Screening
- Small and Large Animal Surgical Models
- GLP- and GMP- Laboratory Studies for FDA Submissions
- Military Programs